Immunofluorescence revealed an abundant expression of Oct4 among cervical cancer samples (positive signal in approximately 60% of the cancers) (Fig 1C), underscoring the validity of expression differences described in our conclusions from the TCGA data. The gene discussed is POU5F1; the disease is cervical cancer.